Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution | ETON Stock NewsStockTitan·1 day ago, 09:50 PMETON+3.15%
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVBrttnews·Jul 24 at 05:31 AMETON+3.15%ADVB+0.92%
Biotech Stocks At 52-Week Highs - CPHI Soars +790%, XNCR, ETON, TXG, ACHCrttnews·Jul 22 at 04:48 AMETON+3.15%CPHI-7.69%
Eton Pharmaceuticals (ETON) Could Be 18% Undervalued As Valuation Questions BuildSimplywall·Jul 14 at 08:11 PMETON+3.15%
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year High - Here's WhyMarket Beat·Jul 2 at 01:20 PMETON+3.15%
Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 millionPUBT·Jun 17 at 04:08 PMETON+3.15%
Eton Pharmaceuticals, Inc. $ETON Shares Sold by UBS Group AGMarket Beat·May 28 at 05:49 AMETON+3.15%LABU-4.04%
Eton Pharmaceuticals Chief Business Officer Sold Shares Worth Over $3.2MTradingView·May 27 at 05:30 PMETON+3.15%IBB-1.04%
Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDOnasdaq·May 20 at 02:45 AMETON+3.15%IBBQ-1.06%
